ChromaDex Corp. (CDXC): Products for Healthy Aging Offer Enormous Sales Potential!
Reading Time: 2 minutes
ChromaDex Corp. (CDXC) is a bioscience company specializing in healthy aging. The company is a pioneer in the research of nicotinamide adenine dinucleotide (NAD+), an essential coenzyme whose levels decline with age. ChromaDex has developed and patented the NAD+ precursor nicotinamide riboside (NR), marketed under the brand name Niagen. This product serves as the main ingredient of the consumer product Tru Niagen, which aims to increase NAD+ levels and thereby support healthy aging. In addition to Tru Niagen, ChromaDex also offers Niagen IV, an...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
